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The performance of Boehringer Mannheim’s BM/Hitachi
911 was evaluated for three months. The mean coeffcient of
variation (CV) of the within-run and between-run imprecision of
the 16 analytes were less than 1"161o (range 0"47-2"381o) and
1"35% (range 0"62-2"93,,4o), respectively. A linearity study for the
various assays covered clinically important levels. No relevant drift
was observed during an eight-hour assay nor was any sample-related
carry-over detected. In all cases, the regression analyses (slopes)
of the results obtainedfrom BM/Hitachi 911 and 717 were between
the extreme values of 0"94 and 1"05. During the three months of
operation, no major problem was encountered. The BM/Hitachi
911 wasfound to be easily operated, to require minimal attention
and simple daily maintenance during operation.
Introduction
Objective analytical performance evaluations are important
to clinical laboratories when looking at the selection of
new instruments [1-4]. The BM/Hitachi 911 is a
very recent selective access analyser from Boehringer
Mannheim GmbH. The photometric unit of the 911
allows the grating spectrophotometer unit to be used in
monochromatic or bichromatic mode at 12 fixed wave-
lengths. The cycle time per test is 20 seconds and the
throughput is 360 photometric tests an hour; throughput
can be increased if the ISE unit is used.
The two-reagent disk units contain all the test materials
necessary for 52 different analytical procedures with 800
routine samples, 800 rerun samples and 200 stat samples.
The sample volumes range from 3-50 lxl, in lal stepwise
increments. The reagent probe is capable of delivering
maximum reagent volume of350 lal and minimum volume
of 250 pl. The analyser tested was equipped with an
optical bar-code reader for a primary tube in sample disks
and in both reagent disks and an RS-232 interface allows
a bidirectional link to a host computer.
The study reported in this paper evaluated the pertbrmance
of BM/Hitachi 911 with 16 analytes (see table 1).
Within-run and between-run imprecisions, linearity,
analyte drift, sample carry-over and correlation are
reported.
Materials and methods
Instruments
A BM/Hitachi 717 (Boehringer Mannheim GmbH) was
used for comparison with the BM/Hitachi 911 (Boehringer
Mannheim GmbH)
Materials:
All reagents and calibrators, unless otherwise stated, were
from Boehringer Mannheim GmbH and were prepared
as described in the manufacturer’s literature.
Table 1. Tesl, method and assay condition used on the BM/Hitachi 717 and BM/Hitachi 911.
Wavelength (nm)
Analyte Method Main Sub
Volume used (lxl)
Sample
Total
reagent
Glucose Glucose oxidase 505 700
BUN Urease (UV) 340 415
Creatinine Jaff reaction 505 570
Uric acid Uricase-POP-PAP 505 700
Cholesterol Cholesterol oxidase-PAP 505 700
Triglyceride GPO-PAP 505 700
Total protein Biuret 546 700
Albumin BCG 600 700
Total bilirubin Dichlorophenyl (DPD) method 570 700
AST SCE method 340 376
ALT SCE method 340 376
Alk. phosphatase PNP 415 700
Total calcium O-cresolphthalein complexone 546 700
Phosphate Ammonium molybdate (UV) 340 376
LDH Pyruvate-lactate 340 376
CK Optimized standard method (UV) 340 415
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Specimens."
One hundred serum samples, ranging from normal to
pathological values, were used in the study. Each serum
was divided equally and assayed either in the BM/Hitachi
911 or 717. The comparative study was obtained by
regression analysis of the values of each serum tbr
16 analytes determined using minimized sum of squares.
The linearity study was carried out using high level
concentration specimens.
Control sera"
The control sera used were"
(1) Boehringer Precinorm lot 175303 (Germany).
(2) Corning lot 020002, 020103, 025103 and 037101
(USA). In method calibration, the same calibrator
(lot 759350) was used on both of the BM/Hitachi 911
and 717.
Table 2. Within-run and between-run imprecision of 16 analytes at three concentrations (N 20).
Within-run Between-run
Analyte Imprecision Imprecision
(unit) Mean SD CV() Mean SD CV()
G1ucose 6"52 0-05 0"63 6"54 0"04 0"68"
(mmol/1) 9"72 0"11 1"09 9"74 0"11 1"12
17"00 0" 11 0"60 17"05 0" 11 0"62
BUN 4" 13 0"04 0"93 4" 18 0"05 1"23"
(mmol/1) 8"52 0" 15 1"78 8"62 0" 17 1"95
13"04 0" 18 1"42 13" 13 0"20 1"56
Creatinine 189" 17 4"51 2"38 190"94 5"39 2"82
(gmol/1) 369"07 7"60 2"06 374"90 8"31 2"22
720"46 6"36 0"88 721"32 7" 16 0"99
Uric acid 294-00 3"03 1"03 296-79 4"88 1-64
(gmol/1) 513"99 4"82 0"94 590"73 5"35 0-91
614"83 5"53 0"90 622"26 5-71 0"92
Cholesterol 3" 10 0"02 0"68 3" 11 0"03 0"84"
(mmol/1) 3"36 0"59 1"75 3"36 0"06 "82
4"44 0"02 0"47 4"45 0"02 0"52
Triglyceride 1"32 0"01 0"76 1"32 0"01 0"76"
(mmol/1) 1"60 0"01 0"63 1"61 0"01 0"62
1"73 0"02 1"15 1"74 0"02 1"15
Total protein 50"81 0"98 1"93 51"01 1"01 1-98
(g/l) 51"00 0"31 0"61 51"50 0"40 0"77
61" 13 0"35 0"57 62"00 0"41 0"66
Albumin 30"20 0"30 0"99 31"00 0"45 1-45"
(g/l) 36" 10 0"51 1"41 36"40 0"56 1"54
36"53 0"52 1"42 36"78 0"64 1"74
Total bilirubin 35"91 0"72 2"00 37"62 0"87 2"32
(gmol/1) 72"73 1"42 1"95 73"89 1"56 2" 10
119"87 1"44 1"20 121"41 1"47 1-21
AST 50"60 0"49 0"96 51"20 0"91 1"78
(U/1) 104"92 1"89 1"80 108" 12 1"98 1"83
205"40 1"92 0"93 206" 10 1"94 0"94
ALT 44"60 0"54 1"21 45" 10 0"62 1"37"
(U/l) 88"85 1" 14 1"28 89"94 1"25 1"38
106"80 0"94 0"88 107"20 1"21 1" 13
ALP 74"31 1"03 1"38 75"24 1"13 1"49
(U/l) 224"81 2"14 0"95 225"40 2"41 1"07
317"46 4"07 1"28 318"42 4" 10 1"29
Total calcium 2" 13 0"05 2"35 2" 14 0"06 2"93"
(mmol/1) 3"07 0"05 1-70 3" 12 0"07 2"40
3"36 0"05 1"48 3"38 0"07 2"07
Phosphate 1"59 0"02 1" 14 1"61 0"02 1"22
(mmol/1) 2"38 0"03 1" 10 2"41 0"03 1"31
2"41 0"03 1-05 2"42 0"03 1"25
LDH 292" 10 2" 16 0"74 292"50 2"46 0"84
(U/l) 586"69 4" 10 0"70 589"97 4"90 0"83
955"20 5’ 10 0"53 957" 10 8" 10 0"85
CK 248" 10 2" 13 0"86 249"40 2"48 0"99"
(U/l) 439"00 3" 10 0"71 441"24 3"41 0"77
505"00 2"71 0"54 506"20 3"41 0"67
Where: a Boehringer precinorm lot 175303, Germany; Ciba Corning: lot 020002, USA; Ciba Corning: lot 037 l01, USA.
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Table 3. Sample-related carry-over of 16 analytes.
Concentration
Analyte Unit High (h) Low (1)
Carry-over, when
high as contaminant
Carry-over, when
low as contaminant
Glucose mmol/1 16"2
BUN mmol/1 8"9
Creatinine lamol/1 725
Uric acid gmol/1 501
Cholesterol mmol/1 4"0
Triglyceride mmol/1 1"8
Total protein g/1 61
Albumin g/1 40
Total bilirubin gmol/1 163
AST U/1 185
ALT U/1 92
Alk. phosphatase U/1 287
Total calcium mmol/1 3"
Phosphate mmol/1 2"3
LDH U/1 950
CK U/1 515
4"6
2"3
183
291
3"2
0"9
48
33
10
32
32
99
2"3
0"9
316
142
0 -0"34
0"71 -0"57
0 1"22
0 0
0 -0"81
1"2 -0"61
0 0
0 0
0 "05
0 1"07
0 "08
0 1"36
1-0 0
0 1.39
0 0"21
0 -1"74
(3) The reagents for determinations of glucose, AST and
ALT were from Wako (Japan) and Ames (Italy),
respectively.
Melhods
The methods and assay conditions used in this study on
BM/Hitachi 717 or 911 are summarized in table 1.
Results
Imprecision
Within-run and between-run imprecision was investigated
with three different levels of control sera. The within-run
imprecision was assayed 20 times in the same batch, and
between-run imprecision was tested using the same sera
on 20 consecutive batches. Data on the within-run and
between-run imprecision are presented in table 2. The
percentage of coefficient of variation (% CV) of both
assays was less than 3%.
Accuracy and linearity
A linearity study was performed using a high con-
centration control serum diluted with isotonic saline. The
diluted sera were assayed in duplicate and the mean values
obtained. The difference between calculated target and
observed value was used for assessing accuracy. The upper
limit of each analyte obtained from the study is shown in
figure 1. The upper limits were in close agreement with
the expected ranges claimed by the manufacturer.
The drift of 16 analytes was assayed using two control
sera analysed at hourly intervals tbr eight hours. The value
determined at zero hours were performed in triplicate and
the subsequent determinations were perIbrmed once. The
pooled sera were aliquoted in tightly closed vials and kept
in a refrigerator. Prior to the assay, the aliquot was
transferred to a sample cup and left at room temperature
for 10 min. None of the analytes showed a deviation more
than5 (see figure 2(a) and 2(b)).
Sample carry-over
Carry-over caused by a sample probe was assayed using
Bennet’s model (6). The assay was performed in three
successive sample portions: high concentration (h ha)
low concentration (/1 la) and same high concentration
(h ha). All samples were assayed in triplicate and the
percentage carry-over was calculated as tbllow:
or
High samples x 100
h2
Low samples x 100
12
Data presented in table 3 show that there was no
appreciable carry-over in any analytes. The overall
percentage carry-over was less than 2.
Correlation
One hundred samples from normal to pathological levels
were divided in half and assayed simultaneously in the
BM/Hitachi 911 or 717. Table 4 presents the regression
analysis of 16 analytes. The extreme slope values obtained
were 0"91 and 1"09, and those for intercepts were -8"22
and 0"61, respectively. This finding suggested that the two
instruments performed similarly.
Discussion
Total analytical imprecision is the summation of the
variances arising from both chemical and instrumental
factors [1, 7]. In this study, the CVs of between-run
imprecision in three control sera were acceptable < 3).
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Table 4. Regression analysis of 16 analytes on BM/Hitachi
717(x) and 911(y), where N 100.
Regression analysis
(Y bx + a)
Analyte Unit b a
Glucose mmol/1 0"96 0"99 -0"007
BUN mmol/1 1"05 0"98 -0"023
Creatinine gmol/1 1"09 0"99 -8"22
Uric acid gmol/1 0"99 0"99 7"77
Cholesterol mmol/1 0"94 0"98 0"003
Triglyccride mmol/1 0"97 0"99 0"0002
Total protein g/1 "01 0"99 0"47
Albumin g/1 0"99 0"99 0’ 10
Total bilirubin gmol/1 0"91 0"99 -0" 11
AST U/1 1"05 0"99 0" 19
ALT U/1 1"01 0"99 -0"20
Alk. phosphatase U/1 0"98 0"99 2"83
Total calcium mmol/1 0"97 0"98 0"030
Phosphate mmol/1 0"96 0"99 -0"006
LDH U/1 1"01 0"99 0"61
CK U/1 0"99 0"99 0"48
According to the quality specification for between-run
analytical imprecision proposed by a Working Group of
EGE-Lab [8], it was shown that the analytical system
achieved these specifications in almost all cases (table 5).
This finding reflected the good quality spectrophotometer
and pipetting systems. However, the mean values for each
analyte in the investigation ofimprecision were consistently
slightly higher between run compared with within run.
This could be due to a slight change in the biological
matrix during the storage of control serum. Photometric
linearity was adequate in all tests (see figure 1) with no
drift detected in any various analytes during an eight-hour
assay. There is good correlation (r 0"97-0"99) between
the results obtained from BM/Hitachi 91 and 717. There
were no problems during the installdtion of BM/Hitachi
911; and there were no instrument failures during the
evaluation study. Laboratory staff learnt to operate and
maintain the equipment within three days. The operator’s
manual and guidelines for trouble-shooting are easily
understood.
In conclusion, the BM/Hitachi 911 fulfilled the acceptance
criteria for analytical performance. This instrument is a
flexible, convenient and easy-to-use analyser for either
batch or random access work. Its design and operational
simplicity provides reliable analytical data. The BM/
Hitachi 911 is well-suited to routine operation and
emergency analyses for small and medium-sized laboratories,
and as a back-up system for large laboratories.
Table 5. Comparison of between-run imprecision proposed by the
Working Group of EGE-Lab and BM/Hitachi 911.
BH/Hitachi 911
Working
Analyte Group* % CV (Mean)
Glucose 2"2 1"12
BUN 6"3 1"95
Creatinine 2"2 2"82
Uric acid 4"2 1"64
Cholesterol 2"7 1"82
Triglyceride 11 "5 "21
Total protein 1"4 1"98
Albumin 1"4 [ "8] 1-74
Total bilirubin 11"3 2"32
AST 7"2 1"83
ALT 13"6 1"38
Total calcium 0"9 [1"5] 2"93
Phosphate 4"0 1"31
LDH 3"9 0"85
CK 20"7 0"99
(9"74 mmol/1)
(8"62 mmol/1)
190"9 gmol/1)
296"8 lamol/1)
(3"36 mmol/1)
(1"74 mmol/1)
(51.0 g/l)
(36"8 g/l)
(37"6 gmol/1)
108-1 U/l)
(89"9
(2"14 mmol/1)
(2"41 mmol/1)
(957.1 U/l)
(249"4 U/l)
Where * Proposed quality specification of between-run imprecision
CV) by a Working Group of EGE-Lab [8].
interim quality specifications proposed by the Working Group.
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